Scientific rationale supporting the clinical development strategy for the investigational Aurora A kinase inhibitor alisertib in cancer

by Jeffrey A Ecsedy, Huifeng eNiu, Mark eManfredi
Published 2015-08-01

Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors

by Jeffrey A. Ecsedy, Herbert C. Yohe, Alan J. Bergeron, Thomas N. Seyfried
Published 1998-11-01

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models

by S. Lindsey eDavis, S. Lindsey eDavis, Kelli M. Robertson, Todd M. Pitts, Todd M. Pitts, John J. Tentler, John J. Tentler, Erica L. Bradshaw-Pierce, Erica L. Bradshaw-Pierce, Erica L. Bradshaw-Pierce, Peter J. Klauck, Stacey M. Bagby, Stephanie L. Hyatt, Heather M. Selby, Anna eSpreafico, Jeffrey A Ecsedy, John J. Arcaroli, John J. Arcaroli, Wells A. Messersmith, Wells A. Messersmith, Aik Choon eTan, Aik Choon eTan, S. Gail eEckhardt, S. Gail eEckhardt
Published 2015-06-01